Alambic Investment Management, L.P.
Reported holdings as of Q3 2020, from 8 quarterly filings.
This filer last reported in Q3 2020; the most recent quarter on file across all filers is Q2 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| MITEK SYS INC | MITK | $452.0K | 35,511 | +4.11pp | 4q | +1.4%+$6.4K | |
| CHANNELADVISOR CORP | ECOM | $433.0K | 29,943 | +2.99pp | 8q | -32.4%-$207.5K | |
| ZYNGA INC | ZNGA | $401.0K | 44,000 | +2.11pp | 5q | -54.0%-$470.3K | |
| CENTRUS ENERGY CORP | LEU | $356.0K | 42,506 | +2.36pp | 4q | -30.9%-$158.9K | |
| MONSTER BEVERAGE CORP NEW | MNST | $345.0K | 4,300 | +2.46pp | 4q | -43.4%-$264.8K | |
| ANAPTYSBIO INC | ANAB | $307.0K | 20,800 | +1.93pp | 4q | -18.9%-$71.6K | |
| PERSONALIS INC | PSNL | $306.0K | 14,104 | +2.90pp | 5q | +0.6%+$1.7K | |
| LUMINEX CORP DEL | LMNX | $302.0K | 11,500 | +2.51pp | 4q | +17.3%+$44.6K | |
| SCIPLAY CORPORATION | SCPL | $269.0K | 16,608 | +2.39pp | 4q | +9.3%+$22.8K | |
| CORCEPT THERAPEUTICS INC | CORT | $267.0K | 15,323 | +1.67pp | 4q | -48.7%-$253.1K | |
| CAMBIUM NETWORKS CORP | CMBMF | $258.0K | 15,319 | +2.38pp | 5q | -37.5%-$154.9K | |
| TECHTARGET INC | TTGT | $233.0K | 5,300 | +1.81pp | 5q | -46.5%-$202.2K | |
| GLU MOBILE INC | GLUU | $223.0K | 29,040 | +1.64pp | 4q | -15.9%-$42.2K | |
| COSTAR GROUP INC | CSGP | $221.0K | 260 | - | new | NEW | |
| CONCERT PHARMACEUTICALS INC | CNCE | $196.0K | 19,934 | +1.70pp | 4q | +11.4%+$20.0K | |
| TRIPLE-S MGMT CORP | GTS | $196.0K | 10,978 | +1.31pp | 8q | -37.3%-$116.4K | |
| INFUSYSTEM HLDGS INC | INFU | $174.0K | 13,584 | +1.48pp | 4q | -8.7%-$16.7K | |
| NEW HOME CO INC | NWHM | $165.0K | 30,367 | +1.35pp | 5q | -44.5%-$132.3K | |
| ORION ENERGY SYS INC | OESXXXXX | $164.0K | 21,663 | +1.03pp | 5q | -75.4%-$502.9K | |
| ASPEN AEROGELS INC | ASPN | $155.0K | 14,133 | +1.24pp | 5q | -49.4%-$151.3K | |
| ACLARIS THERAPEUTICS INC | ACRS | $154.0K | 59,766 | +1.32pp | 6q | -34.1%-$79.7K | |
| COMMUNICATIONS SYS INC | JCS | $126.0K | 32,926 | +0.29pp | 4q | -61.7%-$203.4K | |
| PHOTRONICS INC | PLAB | $121.0K | 12,100 | - | new | NEW | |
| GENASYS INC | GNSS | $119.0K | 19,290 | +0.59pp | 3q | -67.0%-$241.4K | |
| DNOW INC | DNOW | $115.0K | 25,300 | - | new | NEW | |
| STRONGBRIDGE BIOPHARMA PLC | SBBP | $114.0K | 54,164 | +0.67pp | 6q | -11.7%-$15.2K | |
| DZS INC | DZSIQ | $111.0K | 11,879 | - | new | NEW | |
| LUNA INNOVATIONS INC | LUNA | $111.0K | 18,513 | -0.25pp | 8q | -81.6%-$491.9K | |
| CLEAN ENERGY FUELS CORP | CLNE | $110.0K | 44,300 | +0.88pp | 5q | -25.4%-$37.5K | |
| NEURONETICS INC | STIM | $107.0K | 22,026 | +0.88pp | 7q | -64.4%-$193.4K | |
| FITBIT INC | FIT | $102.0K | 14,607 | +0.88pp | 4q | HELD | |
| KEZAR LIFE SCIENCES INC | KZR | $102.0K | 21,135 | +0.84pp | 5q | -2.2%-$2.3K | |
| AMTECH SYS INC | ASYS | $96.0K | 19,723 | +0.41pp | 8q | -62.5%-$160.3K | |
| GSI TECHNOLOGY INC | GSIT | $87.0K | 15,502 | +0.13pp | 8q | -66.1%-$169.4K | |
| ENERGY RECOVERY INC | ERII | $86.0K | 10,500 | - | new | NEW | |
| RETRACTABLE TECHNOLOGIES INC | RVP | $86.0K | 12,850 | +0.29pp | 3q | -65.5%-$163.0K | |
| INNOVATIVE SOLUTIONS & SUPPO | ISSC | $84.0K | 12,212 | +0.66pp | 3q | -42.6%-$62.4K | |
| MARCHEX INC | MCHX | $81.0K | 38,126 | +0.71pp | 8q | -13.4%-$12.6K | |
| SATSUMA PHARMACEUTICALS INC | STSA | $81.0K | 20,711 | - | new | NEW | |
| INTEVAC INC | IVAC | $78.0K | 14,191 | +0.32pp | 7q | -63.9%-$137.8K | |
| NEOPHOTONICS CORP | NPTN | $78.0K | 12,840 | -1.05pp | 8q | -85.0%-$442.3K | |
| RIMINI STR INC DEL | RMNI | $78.0K | 24,089 | +0.70pp | 5q | +102.1%+$39.4K | |
| CATALYST BIOSCIENCES INC | CBIO | $76.0K | 17,681 | - | new | NEW | |
| HARVARD BIOSCIENCE INC | HBIO | $76.0K | 25,398 | +0.53pp | 8q | -35.0%-$40.9K | |
| ORION GROUP HLDGS INC | ORN | $71.0K | 25,828 | +0.50pp | 4q | -27.3%-$26.6K | |
| A10 NETWORKS INC | ATEN | $70.0K | 11,000 | - | new | NEW | |
| COMMERCIAL VEH GROUP INC | CVGI | $70.0K | 10,735 | +0.59pp | 8q | -56.8%-$91.9K | |
| OSMOTICA PHARMACEUTICALS PLC | RVLPQ | $68.0K | 12,516 | -0.06pp | 5q | -73.9%-$192.6K | |
| TELENAV INC | TNAV | $67.0K | 18,553 | -0.62pp | 4q | -81.1%-$288.3K | |
| EVERSPIN TECHNOLOGIES INC | MRAM | $65.0K | 11,433 | +0.41pp | 4q | -33.2%-$32.2K | |
| CYCLERION THERAPEUTICS INC | CYCN | $63.0K | 10,298 | +0.38pp | 4q | -51.1%-$65.9K | |
| GRITSTONE BIO INC | GRTSQ | $57.0K | 21,655 | - | new | NEW | |
| ARC DOCUMENT SOLUTIONS INC | ARC | $54.0K | 60,143 | +0.36pp | 8q | -34.6%-$28.6K | |
| ACCURAY INC DEL | ARAY | $54.0K | 22,354 | +0.44pp | 8q | -24.6%-$17.6K | |
| SYNLOGIC INC | SYBX | $52.0K | 25,901 | +0.36pp | 5q | -37.0%-$30.5K | |
| ANTARES PHARMA INC | ATRS | $45.0K | 16,769 | +0.18pp | 4q | -63.2%-$77.3K | |
| FLUENT INC | FLNT | $45.0K | 18,179 | +0.37pp | 7q | -32.6%-$21.8K | |
| EMCORE CORP | EMKR | $44.0K | 13,390 | +0.37pp | 7q | -1.5% | |
| NIAGEN BIOSCIENCE INC | NAGE | $43.0K | 10,810 | - | new | NEW | |
| ENTASIS THERAPEUTICS HLDGS I | ETTX | $42.0K | 20,682 | - | new | NEW | |
| GLYCOMIMETICS INC | GLYC | $42.0K | 13,796 | - | new | NEW | |
| COTY INC | COTY | $41.0K | 15,200 | - | new | NEW | |
| SAVARA INC | SVRA | $40.0K | 36,546 | - | new | NEW | |
| MEI PHARMA INC | MEIPXXXX | $39.0K | 12,500 | - | new | NEW | |
| RED LION HOTELS CORP | RLH | $38.0K | 17,688 | +0.31pp | 4q | HELD | |
| DURECT CORP | DRRX | $36.0K | 20,880 | +0.27pp | 4q | +0.9% | |
| ALASKA COMMUNICATIONS SYS GR | ALSK | $32.0K | 15,800 | +0.25pp | 8q | +6.8%+$2.0K | |
| HELIX ENERGY SOLUTIONS GRP I | HLX | $31.0K | 12,712 | - | new | NEW | |
| SYNACOR INC | SYNC | $25.0K | 16,700 | +0.22pp | 5q | -18.1%-$5.5K | |
| VYNE THERAPEUTICS INC | VYNEXXXX | $25.0K | 15,200 | - | new | NEW | |
| ABEONA THERAPEUTICS INC | ABEO | $24.0K | 23,112 | - | new | NEW | |
| PIERIS PHARMACEUTICALS INC | PIRS | $23.0K | 10,900 | - | new | NEW | |
| FORUM ENERGY TECHNOLOGIES IN | FET | $10.0K | 18,724 | +0.06pp | 6q | -44.0%-$7.9K |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $1.1M | 12.1% |
| Semiconductors & Electronics | $650.0K | 7.1% |
| Computer Hardware | $522.0K | 5.7% |
| Medical Devices | $421.0K | 4.6% |
| Mining & Metals | $356.0K | 3.9% |
| Food, Drink & Tobacco | $345.0K | 3.8% |
| Business Services | $344.0K | 3.8% |
| Industrials | $307.0K | 3.4% |
| Healthcare Services | $306.0K | 3.4% |
| Telecom & Media | $233.0K | 2.6% |
| Software & IT Services | $165.0K | 1.8% |
| Wholesale & Distribution | $155.0K | 1.7% |
| Other sectors | $323.0K | 3.5% |
| Not classified | $3.9M | 42.7% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q3 2020 | $9.1M | 73 | 19 | 8 | 44 | 109 | 37.7% | 44 |
| Q2 2020 | $39.9M | 163 | 28 | 10 | 112 | 52 | 16.2% | 45 |
| Q1 2020 | $41.3M | 187 | 34 | 22 | 130 | 127 | 15.5% | 41 |
| Q4 2019 | $119.5M | 280 | 92 | 57 | 127 | 109 | 10.5% | 43 |
| Q3 2019 | $132.9M | 297 | 105 | 66 | 116 | 101 | 10.5% | 43 |
| Q2 2019 | $161.9M | 293 | 94 | 54 | 139 | 144 | 10.6% | 44 |
| Q1 2019 | $243.7M | 343 | 126 | 64 | 149 | 86 | 11.1% | 39 |
| Q4 2018 | $237.9M | 303 | 0 | 0 | 0 | 0 | 11.9% | 43 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.